Literature DB >> 19429407

Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups.

Suzanne E Fenton1, Jessica L Reiner2, Shoji F Nakayama2, Amy D Delinsky3, Jason P Stanko4, Erin P Hines4, Sally S White5, Andrew B Lindstrom3, Mark J Strynar3, Syrago-Styliani E Petropoulou2.   

Abstract

Previous studies in mice with multiple gestational exposures to perfluorooctanoic acid (PFOA) demonstrate numerous dose dependent growth and developmental effects which appeared to worsen if offspring exposed in utero nursed from PFOA-exposed dams. To evaluate the disposition of PFOA in the pregnant and lactating dam and her offspring, time-pregnant CD-1 mice received a single 0, 0.1, 1, or 5mg PFOA/kg BW dose (n=25/dose group) by gavage on gestation day 17. Maternal and pup fluids and tissues were collected over time. Pups exhibited significantly higher serum PFOA concentrations than their respective dams, and their body burden increased after birth until at least postnatal day 8, regardless of dose. The distribution of milk:serum PFOA varied by dose and time, but was typically in excess of 0.20. These data suggest that milk is a substantial PFOA exposure route in mice and should be considered in risk assessment modeling designs for this compound.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429407      PMCID: PMC3446208          DOI: 10.1016/j.reprotox.2009.02.012

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  34 in total

1.  Mammary blood flow and cardiac output during initiated involution of the mammary gland in the rabbit.

Authors:  C S Jones; D S Parker
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1988

2.  The effects of engorgement with milk and of suckling on mammary blood flow in the rat.

Authors:  A Hanwell; J L Linzell
Journal:  J Physiol       Date:  1973-08       Impact factor: 5.182

3.  Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures.

Authors:  Sally S White; Kayoko Kato; Lily T Jia; Brian J Basden; Antonia M Calafat; Erin P Hines; Jason P Stanko; Cynthia J Wolf; Barbara D Abbott; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2008-11-27       Impact factor: 3.143

4.  Characterization of risk for general population exposure to perfluorooctanoate.

Authors:  John L Butenhoff; David W Gaylor; John A Moore; Geary W Olsen; Joseph Rodricks; Jeffrey H Mandel; Larry R Zobel
Journal:  Regul Toxicol Pharmacol       Date:  2004-06       Impact factor: 3.271

Review 5.  The developmental toxicity of perfluoroalkyl acids and their derivatives.

Authors:  Christopher Lau; John L Butenhoff; John M Rogers
Journal:  Toxicol Appl Pharmacol       Date:  2004-07-15       Impact factor: 4.219

6.  Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats.

Authors:  J P Vanden Heuvel; B I Kuslikis; M J Van Rafelghem; R E Peterson
Journal:  J Biochem Toxicol       Date:  1991

7.  Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.

Authors:  Erin P Hines; Sally S White; Jason P Stanko; Eugene A Gibbs-Flournoy; Christopher Lau; Suzanne E Fenton
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

8.  Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort.

Authors:  Chunyuan Fei; Joseph K McLaughlin; Robert E Tarone; Jørn Olsen
Journal:  Am J Epidemiol       Date:  2008-05-05       Impact factor: 4.897

9.  Serum protein binding of drugs during and after pregnancy in humans.

Authors:  M Dean; B Stock; R J Patterson; G Levy
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

10.  Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.

Authors:  Jessica L Reiner; Shoji F Nakayama; Amy D Delinsky; Jason P Stanko; Suzanne E Fenton; Andrew B Lindstrom; Mark J Strynar
Journal:  Reprod Toxicol       Date:  2008-11-06       Impact factor: 3.143

View more
  30 in total

1.  Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.

Authors:  Darlene Dixon; Casey E Reed; Alicia B Moore; Eugene A Gibbs-Flournoy; Erin P Hines; Elizabeth A Wallace; Jason P Stanko; Yi Lu; Wendy N Jefferson; Retha R Newbold; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2011-11-28       Impact factor: 3.143

2.  Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Authors:  Madisa B Macon; LaTonya R Villanueva; Katoria Tatum-Gibbs; Robert D Zehr; Mark J Strynar; Jason P Stanko; Sally S White; Laurence Helfant; Suzanne E Fenton
Journal:  Toxicol Sci       Date:  2011-04-11       Impact factor: 4.849

3.  Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors.

Authors:  David R Goulding; Sally S White; Sandra J McBride; Suzanne E Fenton; G Jean Harry
Journal:  Neurotoxicology       Date:  2016-11-22       Impact factor: 4.294

4.  Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study.

Authors:  Cheryl R Stein; Mary S Wolff; Antonia M Calafat; Kayoko Kato; Stephanie M Engel
Journal:  Reprod Toxicol       Date:  2012-05-18       Impact factor: 3.143

5.  Incorporation of fetal and child PFOA dosimetry in the derivation of health-based toxicity values.

Authors:  Kyra Kimberly Kieskamp; Rachel Rogers Worley; Eva D McLanahan; Marc-André Verner
Journal:  Environ Int       Date:  2018-01-08       Impact factor: 9.621

6.  Sex-specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals.

Authors:  Marissa Sobolewski; Katherine Conrad; Joshua L Allen; Hiromi Weston; Kyle Martin; B Paige Lawrence; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2014-10-22       Impact factor: 4.294

7.  The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.

Authors:  Deirdre K Tucker; Madisa B Macon; Mark J Strynar; Sonia Dagnino; Erik Andersen; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2014-12-12       Impact factor: 3.143

Review 8.  Got Milk? Identifying and Characterizing Lactation Defects in Genetically-Engineered Mouse Models.

Authors:  Teneale A Stewart; Felicity M Davis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-19       Impact factor: 2.673

9.  Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha.

Authors:  Cynthia J Wolf; Robert D Zehr; Judy E Schmid; Christopher Lau; Barbara D Abbott
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

10.  Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.

Authors:  Anne E Loccisano; Matthew P Longnecker; Jerry L Campbell; Melvin E Andersen; Harvey J Clewell
Journal:  J Toxicol Environ Health A       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.